Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

How a world class helium discovery in Minnesota was made by chance

The following is a transcription of the above video, and The Market Online has edited it for clarity . Our next company is Pulsar Helium Inc. (TSXV: PLSR) , a company dedicated to defining and developing primary helium assets. President and CEO Thomas Abraham-...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Pampa Metals: Unveiling the Piuquenes Copper Gold Project

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Simply put Pampa Metals (CSE:PM) is a Vancouver‐based post-discovery copper porphyry exploration company listed on the Canadian Stock Exchange, Frank...

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...

First Helium creates two premium helium projects in Alberta

The Alberta-focused, cash-flowing, multi-project helium developer First Helium stock (TSXV:HELI) is seeing a demand for its assets. The company has two premier helium projects in Alberta that are high-value, low risk to high-impact exploration opportunities. The company...

Buzz on the Bullboards: Raise the roof?

Weakness in commodities’ prices have been felt on Bay Street and Wall Street as traders took stock of consumer inflation data. U.S. inflation fell faster than expected in last month to 4.9 per cent, raising chances of a pause in Federal Reserve rate hi...
1 2 3 4 5 6 7 8 9 10 ...